HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

Bempedoic acid cut CV events 30% and all-cause death 27% in statin-intolerant patients

Gokhan Can · Oct 18, 2024 · ♥ 9 reactions · 5 comments · original Facebook post
PCSK9, ezetimibe & newer drugsInflammation & CRPAging & longevity
↻ This is a repost. The main version (highest ranked) is Bempedoic acid cut CV events and may also dampen age-related inflammation · Jul 21, 2026.
AI summary & key facts

Summary of a bempedoic acid outcomes study of 4,206 statin-intolerant, high-risk primary prevention patients: 180 mg daily versus placebo lowered major events, MI, cardiovascular death and all-cause mortality. Gokhan speculates it may be a life-extension drug via ACLY inhibition, which a related study links to senescence-driven inflammation.

Bempedoic Acid as A Potential Life Extension Drug

Study Overview: Bempedoic Acid Cardiovascular Outcomes Study

Key Results

  1. Primary outcome: 30% reduction (HR 0.70, 95% CI 0.55-0.89)
  2. Cardiovascular death, MI, or stroke: 36% reduction (HR 0.64, 95% CI 0.48-0.84)
  3. Myocardial infarction (MI): 39% reduction (HR 0.61, 95% CI 0.39-0.98)
  4. Cardiovascular death: 39% reduction (HR 0.61, 95% CI 0.41-0.92)
  5. All-cause mortality: 27% reduction (HR 0.73, 95% CI 0.54-0.98)

Mechanism of Action

Adverse Effects

ACLY and Cellular Senescence Study

Bempedoic Acid as a Potential Life Extension Drug

Mechanism

Addressing Hallmarks of Aging

Life Extension Potential

Implications and Future Directions

  1. Need for long-term studies to confirm effects on lifespan and healthspan
  2. Importance of assessing long-term safety and optimal use in different populations
  3. Potential to extend healthspan by reducing age-related diseases

Conclusion

Bempedoic acid shows promise as a life extension drug due to its demonstrated cardiovascular benefits and potential to address fundamental aging processes through ACLY inhibition. Further research is needed to fully understand its long-term effects on overall lifespan and health span.

References

1

Neuroscience NewsKey Enzyme Found to Drive Inflammation in Aging Cells - Neuroscience NewsResearchers have discovered that the enzyme ATP-citrate lyase (ACLY) plays a critical role in driving the inflammatory process linked to aging, known as the senescence-associated secretory phenotype (SASP).neurosciencenews.com

2

Paper · JAMAJAMA articlejamanetwork.com

3

Paper · Cell ReportsCell Reports articlecell.com

4

ncbi.nlm.nih.govChecking your browser - reCAPTCHAncbi.nlm.nih.gov

Research cited

#cardiovascular#bempedoicacid#inflammation#aging#healthspan#statins#senescence#prevention
← newer: Expert opinion is shifting toward LDL below 30 mg/dL as optiolder: NLA consensus: apoB testing helps when LDL-C and risk are di →